Amphastar Pharmaceuticals Non-Current Deferred Revenue (Quarterly) Analysis

Amphastar Pharmaceuticals, Inc. (AMPH)

29.45 +1.71 (+6.16%) USD | NASDAQ | Jan 12, 16:00

29.45 0.00 (0.00%) After-Hours: 20:00

View Non-Current Deferred Revenue (Quarterly) for AMPH.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

Eli Lilly & Co.	--
Supernus Pharmaceuticals, Inc.	--
Catalyst Pharmaceuticals, Inc.	--
Pfizer Inc.	--
CorMedix, Inc.	--